Table 6. Summary of Comparison Study between DEM-TACE vs. c-TACE.
| Type | DEM-TACE/c-TACE Numbers | Child-Pugh A/B/C (%) | BCLC A/B/C (%) | Criteria | OR (%) | Median/Mean Survival Time in Month | Survival Rate | |
|---|---|---|---|---|---|---|---|---|
| Lammer et al. 2010 (26) | P | 93 vs. 108 | 82.8/17.2/0 vs. 82.4/17.6/0 | 25.8/74.2/0 vs. 26.9/73.1/0 | EASL | 51.6 vs. 43.5 | N/A | N/A |
| Dhanasekaran et al. 2010 (33) | R | 45 vs. 26 | 48.9/24.4/26.7 vs. 42.3/42.3/15.4 | N/A | N/A | N/A | 20.3/0 vs. 13.4/0 | N/A |
| Ferrer Puchol et al. 2011 (60) | P | 47 vs. 25 | Both group 87.5/12.5/0 | N/A | RECIST | 36.1 vs. 15.3 | 22.4/25.5 vs. 23.6/22.9 | N/A |
| Song et al. 2012 (59) | R | 60 vs. 69 | 93.3/6.7/0 vs. 89.9/10.1/0 | 45/55/0 vs. 40.6/59.4/0 | mRECIST | 81.6 vs. 49.4 | 0/32.2 vs. 0/24.7 | 1 y 88% vs. 67% |
| Kloeckner et al. 2015 (61) | R | 76 vs. 174 | 67.1/28.9/3.9 vs. 59.2/36.8/4 | 10.5/44.7/ 39.5/5.3 vs. 17.2/33.9/ 44.3/4.6 | N/A | N/A | 12.3/0 vs. 13.6/0 | N/A |
| Kucukay et al. 2015 (62) | R | 53 vs. 73 | N/A | 54.7/35.8/9.6 vs. 39.7/54.8/5.5 | N/A | N/A | 0/37.4 vs. 0/39 | 1 y 95.9% vs. 84.9% |
| 2 y 92.3% vs. 74.6% | ||||||||
| Arabi et al. 2015 (63) | R | 35 vs. 25 | 68/32/0 vs. 88/12/0 | N/A | mRECIST | 35 vs. 36 | N/A | 2 y 58% vs. 60% |
| Megías Vericat et al. 2015 (64) | R | 30 vs. 30 | 46.7/53.3/0 vs. 66.7/33.3/0 | N/A | N/A | N/A | N/A | 5 y 20% vs. 30% |
| Rahman et al. 2016 (65) | R | 45 vs. 34 | N/A | 20/80/0 vs. 32/68/0 | mRECIST | 39 vs. 29 | 8.3/0 vs. 4.9/0 | N/A |
| Baur et al. 2016 (66) | R | 14 vs. 18 | 78.6/21.4/0 vs. 58.8/29.7/11.8 | N/A | N/A | N/A | 9.2/0 vs. 10.8/0 | N/A |
| Massani et al. 2017 (67) | R | 28 vs. 54 | 85.7/14.3/0 vs. 83.3/16.7/0 | 10.7/14.3/75 vs. 18.5/50/31.5 | N/A | N/A | 22.7/29.4 vs. 21.8/27 | N/A |
| Lee et al. 2017 (68) | R | 106 vs. 144 | 80.2/19.8/0 vs. 66.0/34.0/0 | 18.9/72.6/8.5 vs. 34/50.7/15.3 | mRECIST | 86.8 vs. 78.3 | 46.6/0 vs. 44.9/0 | N/A |
y = year